MHCC 27-004 Actuarial Consulting - Limiting Prior Authorization for Coverage of Direct-Acting Antivirals for Hepatitis C

Description: The Maryland Department of Health, through the Maryland Health Care Commission (MHCC), is issuing solicitation MHCC 27-004 to procure actuarial consulting services that analyze the effects of limiting prior authorization requirements for insurance coverage of direct-acting antivirals used to treat Hepatitis C. The selected actuarial firm will evaluate the financial, utilization, and policy implications of restricting prior authorization on these pharmaceutical treatments across Maryland's health insurance markets. The contract targets qualified actuarial firms and healthcare policy specialists with experience in pharmaceutical coverage analysis and state health program evaluation, with an estimated value between $100,000 and $500,000.